Lausanne, Switzerland · Founded 2017 · Privately Held (backing)
Operator of a precision therapeutics company intended to discover and develop tissue and cell-selective genomic medicines for fibrotic diseases. HAYA Therapeutics is based in Lausanne, Switzerland and was founded in 2017. Its last reported valuation was $115 million in Apr 2025. It has raised $101 million.
Last reported valuation
$115.5M
Oct 2026
Priced at
—
Total raised
$101.0M
Last round
—
Team — not yet on record
No current team members for HAYA Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of HAYA Therapeutics with a free account
·The complete investor list: 18 names
·Watch HAYA Therapeutics: the Monday email on marks, rounds and moves
